Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × lenvatinib × Clear all

NCT00121719 2023-06-22

An Open Label Dose Escalation Study Of E7080

Phase 1 Completed

82 enrolled 34 charts

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms